BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19922749)

  • 1. Nanoporous inorganic membranes or coatings for sustained drug delivery in implantable devices.
    Gultepe E; Nagesha D; Sridhar S; Amiji M
    Adv Drug Deliv Rev; 2010 Mar; 62(3):305-15. PubMed ID: 19922749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug loading of nanoporous TiO2 films.
    Ayon AA; Cantu M; Chava K; Agrawal CM; Feldman MD; Johnson D; Patel D; Marton D; Shi E
    Biomed Mater; 2006 Dec; 1(4):L11-5. PubMed ID: 18458401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microfabricated nanochannel implantable drug delivery devices: trends, limitations and possibilities.
    Gardner P
    Expert Opin Drug Deliv; 2006 Jul; 3(4):479-87. PubMed ID: 16822223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-ordered nanopore and nanotube platforms for drug delivery applications.
    Losic D; Simovic S
    Expert Opin Drug Deliv; 2009 Dec; 6(12):1363-81. PubMed ID: 19860534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanostructured porous silicon-polymer-based hybrids: from biosensing to drug delivery.
    Bonanno LM; Segal E
    Nanomedicine (Lond); 2011 Dec; 6(10):1755-70. PubMed ID: 22122584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug delivery from structured porous inorganic materials.
    Arruebo M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(1):16-30. PubMed ID: 21374827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of silicon nanoporous membranes and ECM-based microenvironments on neurosecretory cells.
    Lopez CA; Fleischman AJ; Roy S; Desai TA
    Biomaterials; 2006 Jun; 27(16):3075-83. PubMed ID: 16457879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parylene-encapsulated copolymeric membranes as localized and sustained drug delivery platforms.
    Chen M; Huang H; Pierstorff E; Shin E; Robinson E; Ho D
    Ann Biomed Eng; 2009 Oct; 37(10):2003-17. PubMed ID: 19267201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel nanoporous bioceramic spheres for drug delivery application: a preliminary in vitro investigation.
    Simon D; Manuel S; Varma H
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Mar; 115(3):e7-14. PubMed ID: 23453035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioactive properties of nanostructured porous silicon for enhancing electrode to neuron interfaces.
    Moxon KA; Hallman S; Aslani A; Kalkhoran NM; Lelkes PI
    J Biomater Sci Polym Ed; 2007; 18(10):1263-81. PubMed ID: 17939885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoporous SiC: a candidate semi-permeable material for biomedical applications.
    Rosenbloom AJ; Sipe DM; Shishkin Y; Ke Y; Devaty RP; Choyke WJ
    Biomed Microdevices; 2004 Dec; 6(4):261-7. PubMed ID: 15548873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance characteristics of nanoporous carbon membranes for protein ultrafiltration.
    Shah TN; Foley HC; Zydney AL
    Biotechnol Prog; 2007; 23(5):1157-62. PubMed ID: 17848095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo characterization of a novel biocompatible polymer-lipid implant system for the sustained delivery of paclitaxel.
    Ho EA; Vassileva V; Allen C; Piquette-Miller M
    J Control Release; 2005 May; 104(1):181-91. PubMed ID: 15866344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biocompatible implants for the sustained zero-order release of narcotic antagonists.
    Abrahams RA; Ronel SH
    J Biomed Mater Res; 1975 May; 9(3):355-66. PubMed ID: 1176491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Water soluble nanoporous nanoparticle for in vivo targeted drug delivery and controlled release in B cells tumor context.
    De Angelis F; Pujia A; Falcone C; Iaccino E; Palmieri C; Liberale C; Mecarini F; Candeloro P; Luberto L; de Laurentiis A; Das G; Scala G; Di Fabrizio E
    Nanoscale; 2010 Oct; 2(10):2230-6. PubMed ID: 20835434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymers incorporating nitric oxide releasing/generating substances for improved biocompatibility of blood-contacting medical devices.
    Frost MC; Reynolds MM; Meyerhoff ME
    Biomaterials; 2005 May; 26(14):1685-93. PubMed ID: 15576142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled drug release from porous polyelectrolyte multilayers.
    Berg MC; Zhai L; Cohen RE; Rubner MF
    Biomacromolecules; 2006 Jan; 7(1):357-64. PubMed ID: 16398536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug delivery from ordered mesoporous matrices.
    Manzano M; Colilla M; Vallet-Regí M
    Expert Opin Drug Deliv; 2009 Dec; 6(12):1383-400. PubMed ID: 19941412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoporous noninvasive cellular electrical activity-based analysis devices.
    Prasad S; Quijano J
    Clin Lab Med; 2007 Mar; 27(1):75-91. PubMed ID: 17416303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spark plasma sintering synthesis of porous nanocrystalline titanium alloys for biomedical applications.
    Nicula R; Lüthen F; Stir M; Nebe B; Burkel E
    Biomol Eng; 2007 Nov; 24(5):564-7. PubMed ID: 17869173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.